Global Drug Safety and Pharmacovigilance (PV) Software Supply, Demand and Key Producers, 2026-2032
The global Drug Safety and Pharmacovigilance (PV) Software market size is expected to reach $ 411 million by 2032, rising at a market growth of 5.1% CAGR during the forecast period (2026-2032).
Drug Safety and Pharmacovigilance (PV) Software is an automated, information-based tool used by pharmaceutical companies, healthcare institutions, and regulatory authorities to monitor, assess, and prevent adverse drug reactions (ADRs) and safety risks throughout the entire drug lifecycle. It ensures drug compliance, aims to protect public health, improve patient safety, and meet the legal obligations of marketing authorization holders (MAHs).
As global drug regulatory agencies (such as the FDA, EMA, and NMPA) continue to tighten post-marketing regulatory requirements, the traditional manual review-based Individual Case Safety Report (ICSR) processing model can no longer cope with the explosive growth of massive amounts of data. Current leading opinions emphasize that by 2026, the core competitiveness of the market will focus on the full-stack integration capability of AI, that is, whether software can automate the entire process from scanning original documents and automatically sorting cases to providing scientific writing suggestions through large language models and natural language processing. This transformation makes pharmacovigilance software no longer just a database tool, but an indispensable 'risk warning center' in pharmaceutical companies' R&D decision-making.
This report studies the global Drug Safety and Pharmacovigilance (PV) Software demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Drug Safety and Pharmacovigilance (PV) Software, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drug Safety and Pharmacovigilance (PV) Software that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Drug Safety and Pharmacovigilance (PV) Software total market, 2021-2032, (USD Million)
Global Drug Safety and Pharmacovigilance (PV) Software total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Drug Safety and Pharmacovigilance (PV) Software total market, key domestic companies, and share, (USD Million)
Global Drug Safety and Pharmacovigilance (PV) Software revenue by player, revenue and market share 2021-2026, (USD Million)
Global Drug Safety and Pharmacovigilance (PV) Software total market by Type, CAGR, 2021-2032, (USD Million)
Global Drug Safety and Pharmacovigilance (PV) Software total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Drug Safety and Pharmacovigilance (PV) Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Oracle, Veeva Systems, ArisGlobal, IQVIA, EXTEDO, RxLogix, Ennov, Uppsala Monitoring Centre, Medidata, Clarivate, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Drug Safety and Pharmacovigilance (PV) Software market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Drug Safety and Pharmacovigilance (PV) Software Market, By Region:
1. How big is the global Drug Safety and Pharmacovigilance (PV) Software market?
2. What is the demand of the global Drug Safety and Pharmacovigilance (PV) Software market?
3. What is the year over year growth of the global Drug Safety and Pharmacovigilance (PV) Software market?
4. What is the total value of the global Drug Safety and Pharmacovigilance (PV) Software market?
5. Who are the Major Players in the global Drug Safety and Pharmacovigilance (PV) Software market?
6. What are the growth factors driving the market demand?
Drug Safety and Pharmacovigilance (PV) Software is an automated, information-based tool used by pharmaceutical companies, healthcare institutions, and regulatory authorities to monitor, assess, and prevent adverse drug reactions (ADRs) and safety risks throughout the entire drug lifecycle. It ensures drug compliance, aims to protect public health, improve patient safety, and meet the legal obligations of marketing authorization holders (MAHs).
As global drug regulatory agencies (such as the FDA, EMA, and NMPA) continue to tighten post-marketing regulatory requirements, the traditional manual review-based Individual Case Safety Report (ICSR) processing model can no longer cope with the explosive growth of massive amounts of data. Current leading opinions emphasize that by 2026, the core competitiveness of the market will focus on the full-stack integration capability of AI, that is, whether software can automate the entire process from scanning original documents and automatically sorting cases to providing scientific writing suggestions through large language models and natural language processing. This transformation makes pharmacovigilance software no longer just a database tool, but an indispensable 'risk warning center' in pharmaceutical companies' R&D decision-making.
This report studies the global Drug Safety and Pharmacovigilance (PV) Software demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Drug Safety and Pharmacovigilance (PV) Software, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drug Safety and Pharmacovigilance (PV) Software that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Drug Safety and Pharmacovigilance (PV) Software total market, 2021-2032, (USD Million)
Global Drug Safety and Pharmacovigilance (PV) Software total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Drug Safety and Pharmacovigilance (PV) Software total market, key domestic companies, and share, (USD Million)
Global Drug Safety and Pharmacovigilance (PV) Software revenue by player, revenue and market share 2021-2026, (USD Million)
Global Drug Safety and Pharmacovigilance (PV) Software total market by Type, CAGR, 2021-2032, (USD Million)
Global Drug Safety and Pharmacovigilance (PV) Software total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Drug Safety and Pharmacovigilance (PV) Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Oracle, Veeva Systems, ArisGlobal, IQVIA, EXTEDO, RxLogix, Ennov, Uppsala Monitoring Centre, Medidata, Clarivate, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Drug Safety and Pharmacovigilance (PV) Software market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Drug Safety and Pharmacovigilance (PV) Software Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- On-Premises
- Cloud-Based
- Pre-market
- Post-market
- Security Database
- Signal Detection
- Compliance Report
- Other
- Pharma and Biotech Companies
- Contract Research Organizations (CROs)
- Business Process Outsourcing (BPO) Firms
- Other
- Oracle
- Veeva Systems
- ArisGlobal
- IQVIA
- EXTEDO
- RxLogix
- Ennov
- Uppsala Monitoring Centre
- Medidata
- Clarivate
- AB Cube
- Cloudbyz
- Cognizant Technology
- Taimei Technology
- eMedyun
- Bioknow
- Singedi Health
1. How big is the global Drug Safety and Pharmacovigilance (PV) Software market?
2. What is the demand of the global Drug Safety and Pharmacovigilance (PV) Software market?
3. What is the year over year growth of the global Drug Safety and Pharmacovigilance (PV) Software market?
4. What is the total value of the global Drug Safety and Pharmacovigilance (PV) Software market?
5. Who are the Major Players in the global Drug Safety and Pharmacovigilance (PV) Software market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Drug Safety and Pharmacovigilance (PV) Software Introduction
1.2 World Drug Safety and Pharmacovigilance (PV) Software Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Drug Safety and Pharmacovigilance (PV) Software Total Market by Region (by Headquarter Location)
1.3.1 World Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032)
1.3.3 China Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032)
1.3.4 Europe Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032)
1.3.5 Japan Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032)
1.3.6 South Korea Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032)
1.3.7 ASEAN Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032)
1.3.8 India Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drug Safety and Pharmacovigilance (PV) Software Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032)
2.2 World Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Region
2.2.1 World Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Region (2021-2026)
2.2.2 World Drug Safety and Pharmacovigilance (PV) Software Consumption Value Forecast by Region (2027-2032)
2.3 United States Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032)
2.4 China Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032)
2.5 Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032)
2.6 Japan Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032)
2.7 South Korea Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032)
2.8 ASEAN Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032)
2.9 India Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032)
3 WORLD DRUG SAFETY AND PHARMACOVIGILANCE (PV) SOFTWARE COMPANIES COMPETITIVE ANALYSIS
3.1 World Drug Safety and Pharmacovigilance (PV) Software Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Drug Safety and Pharmacovigilance (PV) Software Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Drug Safety and Pharmacovigilance (PV) Software in 2025
3.2.3 Global Concentration Ratios (CR8) for Drug Safety and Pharmacovigilance (PV) Software in 2025
3.3 Drug Safety and Pharmacovigilance (PV) Software Company Evaluation Quadrant
3.4 Drug Safety and Pharmacovigilance (PV) Software Market: Overall Company Footprint Analysis
3.4.1 Drug Safety and Pharmacovigilance (PV) Software Market: Region Footprint
3.4.2 Drug Safety and Pharmacovigilance (PV) Software Market: Company Product Type Footprint
3.4.3 Drug Safety and Pharmacovigilance (PV) Software Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Drug Safety and Pharmacovigilance (PV) Software Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Drug Safety and Pharmacovigilance (PV) Software Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Drug Safety and Pharmacovigilance (PV) Software Consumption Value Comparison
4.2.1 United States VS China: Drug Safety and Pharmacovigilance (PV) Software Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Drug Safety and Pharmacovigilance (PV) Software Companies and Market Share, 2021-2026
4.3.1 United States Based Drug Safety and Pharmacovigilance (PV) Software Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Drug Safety and Pharmacovigilance (PV) Software Revenue, (2021-2026)
4.4 China Based Companies Drug Safety and Pharmacovigilance (PV) Software Revenue and Market Share, 2021-2026
4.4.1 China Based Drug Safety and Pharmacovigilance (PV) Software Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Drug Safety and Pharmacovigilance (PV) Software Revenue, (2021-2026)
4.5 Rest of World Based Drug Safety and Pharmacovigilance (PV) Software Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Drug Safety and Pharmacovigilance (PV) Software Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Drug Safety and Pharmacovigilance (PV) Software Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 On-Premises
5.2.2 Cloud-Based
5.3 Market Segment by Type
5.3.1 World Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026)
5.3.2 World Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2027-2032)
5.3.3 World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DATA RANGE
6.1 World Drug Safety and Pharmacovigilance (PV) Software Market Size Overview by Data Range: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Data Range
6.2.1 Pre-market
6.2.2 Post-market
6.3 Market Segment by Data Range
6.3.1 World Drug Safety and Pharmacovigilance (PV) Software Market Size by Data Range (2021-2026)
6.3.2 World Drug Safety and Pharmacovigilance (PV) Software Market Size by Data Range (2027-2032)
6.3.3 World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Data Range (2027-2032)
7 MARKET ANALYSIS BY FUNCTIONAL MODULES
7.1 World Drug Safety and Pharmacovigilance (PV) Software Market Size Overview by Functional Modules: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Functional Modules
7.2.1 Security Database
7.2.2 Signal Detection
7.2.3 Compliance Report
7.2.4 Other
7.3 Market Segment by Functional Modules
7.3.1 World Drug Safety and Pharmacovigilance (PV) Software Market Size by Functional Modules (2021-2026)
7.3.2 World Drug Safety and Pharmacovigilance (PV) Software Market Size by Functional Modules (2027-2032)
7.3.3 World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Functional Modules (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Drug Safety and Pharmacovigilance (PV) Software Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharma and Biotech Companies
8.2.2 Contract Research Organizations (CROs)
8.2.3 Business Process Outsourcing (BPO) Firms
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026)
8.3.2 World Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2027-2032)
8.3.3 World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Oracle
9.1.1 Oracle Details
9.1.2 Oracle Major Business
9.1.3 Oracle Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.1.4 Oracle Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Oracle Recent Developments/Updates
9.1.6 Oracle Competitive Strengths & Weaknesses
9.2 Veeva Systems
9.2.1 Veeva Systems Details
9.2.2 Veeva Systems Major Business
9.2.3 Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.2.4 Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Veeva Systems Recent Developments/Updates
9.2.6 Veeva Systems Competitive Strengths & Weaknesses
9.3 ArisGlobal
9.3.1 ArisGlobal Details
9.3.2 ArisGlobal Major Business
9.3.3 ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.3.4 ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 ArisGlobal Recent Developments/Updates
9.3.6 ArisGlobal Competitive Strengths & Weaknesses
9.4 IQVIA
9.4.1 IQVIA Details
9.4.2 IQVIA Major Business
9.4.3 IQVIA Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.4.4 IQVIA Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 IQVIA Recent Developments/Updates
9.4.6 IQVIA Competitive Strengths & Weaknesses
9.5 EXTEDO
9.5.1 EXTEDO Details
9.5.2 EXTEDO Major Business
9.5.3 EXTEDO Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.5.4 EXTEDO Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 EXTEDO Recent Developments/Updates
9.5.6 EXTEDO Competitive Strengths & Weaknesses
9.6 RxLogix
9.6.1 RxLogix Details
9.6.2 RxLogix Major Business
9.6.3 RxLogix Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.6.4 RxLogix Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 RxLogix Recent Developments/Updates
9.6.6 RxLogix Competitive Strengths & Weaknesses
9.7 Ennov
9.7.1 Ennov Details
9.7.2 Ennov Major Business
9.7.3 Ennov Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.7.4 Ennov Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Ennov Recent Developments/Updates
9.7.6 Ennov Competitive Strengths & Weaknesses
9.8 Uppsala Monitoring Centre
9.8.1 Uppsala Monitoring Centre Details
9.8.2 Uppsala Monitoring Centre Major Business
9.8.3 Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.8.4 Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Uppsala Monitoring Centre Recent Developments/Updates
9.8.6 Uppsala Monitoring Centre Competitive Strengths & Weaknesses
9.9 Medidata
9.9.1 Medidata Details
9.9.2 Medidata Major Business
9.9.3 Medidata Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.9.4 Medidata Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Medidata Recent Developments/Updates
9.9.6 Medidata Competitive Strengths & Weaknesses
9.10 Clarivate
9.10.1 Clarivate Details
9.10.2 Clarivate Major Business
9.10.3 Clarivate Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.10.4 Clarivate Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Clarivate Recent Developments/Updates
9.10.6 Clarivate Competitive Strengths & Weaknesses
9.11 AB Cube
9.11.1 AB Cube Details
9.11.2 AB Cube Major Business
9.11.3 AB Cube Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.11.4 AB Cube Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 AB Cube Recent Developments/Updates
9.11.6 AB Cube Competitive Strengths & Weaknesses
9.12 Cloudbyz
9.12.1 Cloudbyz Details
9.12.2 Cloudbyz Major Business
9.12.3 Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.12.4 Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Cloudbyz Recent Developments/Updates
9.12.6 Cloudbyz Competitive Strengths & Weaknesses
9.13 Cognizant Technology
9.13.1 Cognizant Technology Details
9.13.2 Cognizant Technology Major Business
9.13.3 Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.13.4 Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Cognizant Technology Recent Developments/Updates
9.13.6 Cognizant Technology Competitive Strengths & Weaknesses
9.14 Taimei Technology
9.14.1 Taimei Technology Details
9.14.2 Taimei Technology Major Business
9.14.3 Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.14.4 Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Taimei Technology Recent Developments/Updates
9.14.6 Taimei Technology Competitive Strengths & Weaknesses
9.15 eMedyun
9.15.1 eMedyun Details
9.15.2 eMedyun Major Business
9.15.3 eMedyun Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.15.4 eMedyun Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 eMedyun Recent Developments/Updates
9.15.6 eMedyun Competitive Strengths & Weaknesses
9.16 Bioknow
9.16.1 Bioknow Details
9.16.2 Bioknow Major Business
9.16.3 Bioknow Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.16.4 Bioknow Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Bioknow Recent Developments/Updates
9.16.6 Bioknow Competitive Strengths & Weaknesses
9.17 Singedi Health
9.17.1 Singedi Health Details
9.17.2 Singedi Health Major Business
9.17.3 Singedi Health Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.17.4 Singedi Health Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Singedi Health Recent Developments/Updates
9.17.6 Singedi Health Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Drug Safety and Pharmacovigilance (PV) Software Industry Chain
10.2 Drug Safety and Pharmacovigilance (PV) Software Upstream Analysis
10.3 Drug Safety and Pharmacovigilance (PV) Software Midstream Analysis
10.4 Drug Safety and Pharmacovigilance (PV) Software Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Drug Safety and Pharmacovigilance (PV) Software Introduction
1.2 World Drug Safety and Pharmacovigilance (PV) Software Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Drug Safety and Pharmacovigilance (PV) Software Total Market by Region (by Headquarter Location)
1.3.1 World Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032)
1.3.3 China Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032)
1.3.4 Europe Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032)
1.3.5 Japan Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032)
1.3.6 South Korea Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032)
1.3.7 ASEAN Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032)
1.3.8 India Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drug Safety and Pharmacovigilance (PV) Software Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032)
2.2 World Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Region
2.2.1 World Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Region (2021-2026)
2.2.2 World Drug Safety and Pharmacovigilance (PV) Software Consumption Value Forecast by Region (2027-2032)
2.3 United States Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032)
2.4 China Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032)
2.5 Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032)
2.6 Japan Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032)
2.7 South Korea Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032)
2.8 ASEAN Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032)
2.9 India Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032)
3 WORLD DRUG SAFETY AND PHARMACOVIGILANCE (PV) SOFTWARE COMPANIES COMPETITIVE ANALYSIS
3.1 World Drug Safety and Pharmacovigilance (PV) Software Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Drug Safety and Pharmacovigilance (PV) Software Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Drug Safety and Pharmacovigilance (PV) Software in 2025
3.2.3 Global Concentration Ratios (CR8) for Drug Safety and Pharmacovigilance (PV) Software in 2025
3.3 Drug Safety and Pharmacovigilance (PV) Software Company Evaluation Quadrant
3.4 Drug Safety and Pharmacovigilance (PV) Software Market: Overall Company Footprint Analysis
3.4.1 Drug Safety and Pharmacovigilance (PV) Software Market: Region Footprint
3.4.2 Drug Safety and Pharmacovigilance (PV) Software Market: Company Product Type Footprint
3.4.3 Drug Safety and Pharmacovigilance (PV) Software Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Drug Safety and Pharmacovigilance (PV) Software Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Drug Safety and Pharmacovigilance (PV) Software Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Drug Safety and Pharmacovigilance (PV) Software Consumption Value Comparison
4.2.1 United States VS China: Drug Safety and Pharmacovigilance (PV) Software Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Drug Safety and Pharmacovigilance (PV) Software Companies and Market Share, 2021-2026
4.3.1 United States Based Drug Safety and Pharmacovigilance (PV) Software Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Drug Safety and Pharmacovigilance (PV) Software Revenue, (2021-2026)
4.4 China Based Companies Drug Safety and Pharmacovigilance (PV) Software Revenue and Market Share, 2021-2026
4.4.1 China Based Drug Safety and Pharmacovigilance (PV) Software Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Drug Safety and Pharmacovigilance (PV) Software Revenue, (2021-2026)
4.5 Rest of World Based Drug Safety and Pharmacovigilance (PV) Software Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Drug Safety and Pharmacovigilance (PV) Software Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Drug Safety and Pharmacovigilance (PV) Software Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 On-Premises
5.2.2 Cloud-Based
5.3 Market Segment by Type
5.3.1 World Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026)
5.3.2 World Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2027-2032)
5.3.3 World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DATA RANGE
6.1 World Drug Safety and Pharmacovigilance (PV) Software Market Size Overview by Data Range: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Data Range
6.2.1 Pre-market
6.2.2 Post-market
6.3 Market Segment by Data Range
6.3.1 World Drug Safety and Pharmacovigilance (PV) Software Market Size by Data Range (2021-2026)
6.3.2 World Drug Safety and Pharmacovigilance (PV) Software Market Size by Data Range (2027-2032)
6.3.3 World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Data Range (2027-2032)
7 MARKET ANALYSIS BY FUNCTIONAL MODULES
7.1 World Drug Safety and Pharmacovigilance (PV) Software Market Size Overview by Functional Modules: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Functional Modules
7.2.1 Security Database
7.2.2 Signal Detection
7.2.3 Compliance Report
7.2.4 Other
7.3 Market Segment by Functional Modules
7.3.1 World Drug Safety and Pharmacovigilance (PV) Software Market Size by Functional Modules (2021-2026)
7.3.2 World Drug Safety and Pharmacovigilance (PV) Software Market Size by Functional Modules (2027-2032)
7.3.3 World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Functional Modules (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Drug Safety and Pharmacovigilance (PV) Software Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharma and Biotech Companies
8.2.2 Contract Research Organizations (CROs)
8.2.3 Business Process Outsourcing (BPO) Firms
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026)
8.3.2 World Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2027-2032)
8.3.3 World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Oracle
9.1.1 Oracle Details
9.1.2 Oracle Major Business
9.1.3 Oracle Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.1.4 Oracle Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Oracle Recent Developments/Updates
9.1.6 Oracle Competitive Strengths & Weaknesses
9.2 Veeva Systems
9.2.1 Veeva Systems Details
9.2.2 Veeva Systems Major Business
9.2.3 Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.2.4 Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Veeva Systems Recent Developments/Updates
9.2.6 Veeva Systems Competitive Strengths & Weaknesses
9.3 ArisGlobal
9.3.1 ArisGlobal Details
9.3.2 ArisGlobal Major Business
9.3.3 ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.3.4 ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 ArisGlobal Recent Developments/Updates
9.3.6 ArisGlobal Competitive Strengths & Weaknesses
9.4 IQVIA
9.4.1 IQVIA Details
9.4.2 IQVIA Major Business
9.4.3 IQVIA Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.4.4 IQVIA Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 IQVIA Recent Developments/Updates
9.4.6 IQVIA Competitive Strengths & Weaknesses
9.5 EXTEDO
9.5.1 EXTEDO Details
9.5.2 EXTEDO Major Business
9.5.3 EXTEDO Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.5.4 EXTEDO Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 EXTEDO Recent Developments/Updates
9.5.6 EXTEDO Competitive Strengths & Weaknesses
9.6 RxLogix
9.6.1 RxLogix Details
9.6.2 RxLogix Major Business
9.6.3 RxLogix Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.6.4 RxLogix Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 RxLogix Recent Developments/Updates
9.6.6 RxLogix Competitive Strengths & Weaknesses
9.7 Ennov
9.7.1 Ennov Details
9.7.2 Ennov Major Business
9.7.3 Ennov Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.7.4 Ennov Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Ennov Recent Developments/Updates
9.7.6 Ennov Competitive Strengths & Weaknesses
9.8 Uppsala Monitoring Centre
9.8.1 Uppsala Monitoring Centre Details
9.8.2 Uppsala Monitoring Centre Major Business
9.8.3 Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.8.4 Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Uppsala Monitoring Centre Recent Developments/Updates
9.8.6 Uppsala Monitoring Centre Competitive Strengths & Weaknesses
9.9 Medidata
9.9.1 Medidata Details
9.9.2 Medidata Major Business
9.9.3 Medidata Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.9.4 Medidata Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Medidata Recent Developments/Updates
9.9.6 Medidata Competitive Strengths & Weaknesses
9.10 Clarivate
9.10.1 Clarivate Details
9.10.2 Clarivate Major Business
9.10.3 Clarivate Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.10.4 Clarivate Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Clarivate Recent Developments/Updates
9.10.6 Clarivate Competitive Strengths & Weaknesses
9.11 AB Cube
9.11.1 AB Cube Details
9.11.2 AB Cube Major Business
9.11.3 AB Cube Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.11.4 AB Cube Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 AB Cube Recent Developments/Updates
9.11.6 AB Cube Competitive Strengths & Weaknesses
9.12 Cloudbyz
9.12.1 Cloudbyz Details
9.12.2 Cloudbyz Major Business
9.12.3 Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.12.4 Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Cloudbyz Recent Developments/Updates
9.12.6 Cloudbyz Competitive Strengths & Weaknesses
9.13 Cognizant Technology
9.13.1 Cognizant Technology Details
9.13.2 Cognizant Technology Major Business
9.13.3 Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.13.4 Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Cognizant Technology Recent Developments/Updates
9.13.6 Cognizant Technology Competitive Strengths & Weaknesses
9.14 Taimei Technology
9.14.1 Taimei Technology Details
9.14.2 Taimei Technology Major Business
9.14.3 Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.14.4 Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Taimei Technology Recent Developments/Updates
9.14.6 Taimei Technology Competitive Strengths & Weaknesses
9.15 eMedyun
9.15.1 eMedyun Details
9.15.2 eMedyun Major Business
9.15.3 eMedyun Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.15.4 eMedyun Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 eMedyun Recent Developments/Updates
9.15.6 eMedyun Competitive Strengths & Weaknesses
9.16 Bioknow
9.16.1 Bioknow Details
9.16.2 Bioknow Major Business
9.16.3 Bioknow Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.16.4 Bioknow Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Bioknow Recent Developments/Updates
9.16.6 Bioknow Competitive Strengths & Weaknesses
9.17 Singedi Health
9.17.1 Singedi Health Details
9.17.2 Singedi Health Major Business
9.17.3 Singedi Health Drug Safety and Pharmacovigilance (PV) Software Product and Services
9.17.4 Singedi Health Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Singedi Health Recent Developments/Updates
9.17.6 Singedi Health Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Drug Safety and Pharmacovigilance (PV) Software Industry Chain
10.2 Drug Safety and Pharmacovigilance (PV) Software Upstream Analysis
10.3 Drug Safety and Pharmacovigilance (PV) Software Midstream Analysis
10.4 Drug Safety and Pharmacovigilance (PV) Software Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Drug Safety and Pharmacovigilance (PV) Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Drug Safety and Pharmacovigilance (PV) Software Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Drug Safety and Pharmacovigilance (PV) Software Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Drug Safety and Pharmacovigilance (PV) Software Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Drug Safety and Pharmacovigilance (PV) Software Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Drug Safety and Pharmacovigilance (PV) Software Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Drug Safety and Pharmacovigilance (PV) Software Players in 2025
Table 12. World Drug Safety and Pharmacovigilance (PV) Software Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Drug Safety and Pharmacovigilance (PV) Software Company Evaluation Quadrant
Table 14. Head Office of Key Drug Safety and Pharmacovigilance (PV) Software Players
Table 15. Drug Safety and Pharmacovigilance (PV) Software Market: Company Product Type Footprint
Table 16. Drug Safety and Pharmacovigilance (PV) Software Market: Company Product Application Footprint
Table 17. Drug Safety and Pharmacovigilance (PV) Software Mergers & Acquisitions Activity
Table 18. United States VS China Drug Safety and Pharmacovigilance (PV) Software Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Drug Safety and Pharmacovigilance (PV) Software Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Drug Safety and Pharmacovigilance (PV) Software Companies, Headquarters (States, Country)
Table 21. United States Based Companies Drug Safety and Pharmacovigilance (PV) Software Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share (2021-2026)
Table 23. China Based Drug Safety and Pharmacovigilance (PV) Software Companies, Headquarters (Province, Country)
Table 24. China Based Companies Drug Safety and Pharmacovigilance (PV) Software Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share (2021-2026)
Table 26. Rest of World Based Drug Safety and Pharmacovigilance (PV) Software Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share (2021-2026)
Table 29. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Drug Safety and Pharmacovigilance (PV) Software Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2027-2032) & (USD Million)
Table 32. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Data Range, (USD Million), 2021 & 2025 & 2032
Table 33. World Drug Safety and Pharmacovigilance (PV) Software Market Size Value by Data Range (2021-2026) & (USD Million)
Table 34. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Data Range (2027-2032) & (USD Million)
Table 35. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Functional Modules, (USD Million), 2021 & 2025 & 2032
Table 36. World Drug Safety and Pharmacovigilance (PV) Software Market Size Value by Functional Modules (2021-2026) & (USD Million)
Table 37. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Functional Modules (2027-2032) & (USD Million)
Table 38. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026) & (USD Million)
Table 40. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2027-2032) & (USD Million)
Table 41. Oracle Basic Information, Manufacturing Base and Competitors
Table 42. Oracle Major Business
Table 43. Oracle Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 44. Oracle Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Oracle Recent Developments/Updates
Table 46. Oracle Competitive Strengths & Weaknesses
Table 47. Veeva Systems Basic Information, Manufacturing Base and Competitors
Table 48. Veeva Systems Major Business
Table 49. Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 50. Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Veeva Systems Recent Developments/Updates
Table 52. Veeva Systems Competitive Strengths & Weaknesses
Table 53. ArisGlobal Basic Information, Manufacturing Base and Competitors
Table 54. ArisGlobal Major Business
Table 55. ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 56. ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. ArisGlobal Recent Developments/Updates
Table 58. ArisGlobal Competitive Strengths & Weaknesses
Table 59. IQVIA Basic Information, Manufacturing Base and Competitors
Table 60. IQVIA Major Business
Table 61. IQVIA Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 62. IQVIA Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. IQVIA Recent Developments/Updates
Table 64. IQVIA Competitive Strengths & Weaknesses
Table 65. EXTEDO Basic Information, Manufacturing Base and Competitors
Table 66. EXTEDO Major Business
Table 67. EXTEDO Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 68. EXTEDO Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. EXTEDO Recent Developments/Updates
Table 70. EXTEDO Competitive Strengths & Weaknesses
Table 71. RxLogix Basic Information, Manufacturing Base and Competitors
Table 72. RxLogix Major Business
Table 73. RxLogix Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 74. RxLogix Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. RxLogix Recent Developments/Updates
Table 76. RxLogix Competitive Strengths & Weaknesses
Table 77. Ennov Basic Information, Manufacturing Base and Competitors
Table 78. Ennov Major Business
Table 79. Ennov Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 80. Ennov Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Ennov Recent Developments/Updates
Table 82. Ennov Competitive Strengths & Weaknesses
Table 83. Uppsala Monitoring Centre Basic Information, Manufacturing Base and Competitors
Table 84. Uppsala Monitoring Centre Major Business
Table 85. Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 86. Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Uppsala Monitoring Centre Recent Developments/Updates
Table 88. Uppsala Monitoring Centre Competitive Strengths & Weaknesses
Table 89. Medidata Basic Information, Manufacturing Base and Competitors
Table 90. Medidata Major Business
Table 91. Medidata Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 92. Medidata Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Medidata Recent Developments/Updates
Table 94. Medidata Competitive Strengths & Weaknesses
Table 95. Clarivate Basic Information, Manufacturing Base and Competitors
Table 96. Clarivate Major Business
Table 97. Clarivate Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 98. Clarivate Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Clarivate Recent Developments/Updates
Table 100. Clarivate Competitive Strengths & Weaknesses
Table 101. AB Cube Basic Information, Manufacturing Base and Competitors
Table 102. AB Cube Major Business
Table 103. AB Cube Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 104. AB Cube Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. AB Cube Recent Developments/Updates
Table 106. AB Cube Competitive Strengths & Weaknesses
Table 107. Cloudbyz Basic Information, Manufacturing Base and Competitors
Table 108. Cloudbyz Major Business
Table 109. Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 110. Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Cloudbyz Recent Developments/Updates
Table 112. Cloudbyz Competitive Strengths & Weaknesses
Table 113. Cognizant Technology Basic Information, Manufacturing Base and Competitors
Table 114. Cognizant Technology Major Business
Table 115. Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 116. Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Cognizant Technology Recent Developments/Updates
Table 118. Cognizant Technology Competitive Strengths & Weaknesses
Table 119. Taimei Technology Basic Information, Manufacturing Base and Competitors
Table 120. Taimei Technology Major Business
Table 121. Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 122. Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Taimei Technology Recent Developments/Updates
Table 124. Taimei Technology Competitive Strengths & Weaknesses
Table 125. eMedyun Basic Information, Manufacturing Base and Competitors
Table 126. eMedyun Major Business
Table 127. eMedyun Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 128. eMedyun Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. eMedyun Recent Developments/Updates
Table 130. eMedyun Competitive Strengths & Weaknesses
Table 131. Bioknow Basic Information, Manufacturing Base and Competitors
Table 132. Bioknow Major Business
Table 133. Bioknow Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 134. Bioknow Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Bioknow Recent Developments/Updates
Table 136. Bioknow Competitive Strengths & Weaknesses
Table 137. Singedi Health Basic Information, Manufacturing Base and Competitors
Table 138. Singedi Health Major Business
Table 139. Singedi Health Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 140. Singedi Health Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Singedi Health Recent Developments/Updates
Table 142. Singedi Health Competitive Strengths & Weaknesses
Table 143. Global Key Players of Drug Safety and Pharmacovigilance (PV) Software Upstream (Raw Materials)
Table 144. Global Drug Safety and Pharmacovigilance (PV) Software Typical Customers
Table 1. World Drug Safety and Pharmacovigilance (PV) Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Drug Safety and Pharmacovigilance (PV) Software Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Drug Safety and Pharmacovigilance (PV) Software Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Drug Safety and Pharmacovigilance (PV) Software Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Drug Safety and Pharmacovigilance (PV) Software Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Drug Safety and Pharmacovigilance (PV) Software Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Drug Safety and Pharmacovigilance (PV) Software Players in 2025
Table 12. World Drug Safety and Pharmacovigilance (PV) Software Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Drug Safety and Pharmacovigilance (PV) Software Company Evaluation Quadrant
Table 14. Head Office of Key Drug Safety and Pharmacovigilance (PV) Software Players
Table 15. Drug Safety and Pharmacovigilance (PV) Software Market: Company Product Type Footprint
Table 16. Drug Safety and Pharmacovigilance (PV) Software Market: Company Product Application Footprint
Table 17. Drug Safety and Pharmacovigilance (PV) Software Mergers & Acquisitions Activity
Table 18. United States VS China Drug Safety and Pharmacovigilance (PV) Software Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Drug Safety and Pharmacovigilance (PV) Software Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Drug Safety and Pharmacovigilance (PV) Software Companies, Headquarters (States, Country)
Table 21. United States Based Companies Drug Safety and Pharmacovigilance (PV) Software Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share (2021-2026)
Table 23. China Based Drug Safety and Pharmacovigilance (PV) Software Companies, Headquarters (Province, Country)
Table 24. China Based Companies Drug Safety and Pharmacovigilance (PV) Software Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share (2021-2026)
Table 26. Rest of World Based Drug Safety and Pharmacovigilance (PV) Software Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share (2021-2026)
Table 29. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Drug Safety and Pharmacovigilance (PV) Software Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2027-2032) & (USD Million)
Table 32. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Data Range, (USD Million), 2021 & 2025 & 2032
Table 33. World Drug Safety and Pharmacovigilance (PV) Software Market Size Value by Data Range (2021-2026) & (USD Million)
Table 34. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Data Range (2027-2032) & (USD Million)
Table 35. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Functional Modules, (USD Million), 2021 & 2025 & 2032
Table 36. World Drug Safety and Pharmacovigilance (PV) Software Market Size Value by Functional Modules (2021-2026) & (USD Million)
Table 37. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Functional Modules (2027-2032) & (USD Million)
Table 38. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026) & (USD Million)
Table 40. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2027-2032) & (USD Million)
Table 41. Oracle Basic Information, Manufacturing Base and Competitors
Table 42. Oracle Major Business
Table 43. Oracle Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 44. Oracle Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Oracle Recent Developments/Updates
Table 46. Oracle Competitive Strengths & Weaknesses
Table 47. Veeva Systems Basic Information, Manufacturing Base and Competitors
Table 48. Veeva Systems Major Business
Table 49. Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 50. Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Veeva Systems Recent Developments/Updates
Table 52. Veeva Systems Competitive Strengths & Weaknesses
Table 53. ArisGlobal Basic Information, Manufacturing Base and Competitors
Table 54. ArisGlobal Major Business
Table 55. ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 56. ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. ArisGlobal Recent Developments/Updates
Table 58. ArisGlobal Competitive Strengths & Weaknesses
Table 59. IQVIA Basic Information, Manufacturing Base and Competitors
Table 60. IQVIA Major Business
Table 61. IQVIA Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 62. IQVIA Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. IQVIA Recent Developments/Updates
Table 64. IQVIA Competitive Strengths & Weaknesses
Table 65. EXTEDO Basic Information, Manufacturing Base and Competitors
Table 66. EXTEDO Major Business
Table 67. EXTEDO Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 68. EXTEDO Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. EXTEDO Recent Developments/Updates
Table 70. EXTEDO Competitive Strengths & Weaknesses
Table 71. RxLogix Basic Information, Manufacturing Base and Competitors
Table 72. RxLogix Major Business
Table 73. RxLogix Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 74. RxLogix Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. RxLogix Recent Developments/Updates
Table 76. RxLogix Competitive Strengths & Weaknesses
Table 77. Ennov Basic Information, Manufacturing Base and Competitors
Table 78. Ennov Major Business
Table 79. Ennov Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 80. Ennov Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Ennov Recent Developments/Updates
Table 82. Ennov Competitive Strengths & Weaknesses
Table 83. Uppsala Monitoring Centre Basic Information, Manufacturing Base and Competitors
Table 84. Uppsala Monitoring Centre Major Business
Table 85. Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 86. Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Uppsala Monitoring Centre Recent Developments/Updates
Table 88. Uppsala Monitoring Centre Competitive Strengths & Weaknesses
Table 89. Medidata Basic Information, Manufacturing Base and Competitors
Table 90. Medidata Major Business
Table 91. Medidata Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 92. Medidata Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Medidata Recent Developments/Updates
Table 94. Medidata Competitive Strengths & Weaknesses
Table 95. Clarivate Basic Information, Manufacturing Base and Competitors
Table 96. Clarivate Major Business
Table 97. Clarivate Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 98. Clarivate Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Clarivate Recent Developments/Updates
Table 100. Clarivate Competitive Strengths & Weaknesses
Table 101. AB Cube Basic Information, Manufacturing Base and Competitors
Table 102. AB Cube Major Business
Table 103. AB Cube Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 104. AB Cube Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. AB Cube Recent Developments/Updates
Table 106. AB Cube Competitive Strengths & Weaknesses
Table 107. Cloudbyz Basic Information, Manufacturing Base and Competitors
Table 108. Cloudbyz Major Business
Table 109. Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 110. Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Cloudbyz Recent Developments/Updates
Table 112. Cloudbyz Competitive Strengths & Weaknesses
Table 113. Cognizant Technology Basic Information, Manufacturing Base and Competitors
Table 114. Cognizant Technology Major Business
Table 115. Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 116. Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Cognizant Technology Recent Developments/Updates
Table 118. Cognizant Technology Competitive Strengths & Weaknesses
Table 119. Taimei Technology Basic Information, Manufacturing Base and Competitors
Table 120. Taimei Technology Major Business
Table 121. Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 122. Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Taimei Technology Recent Developments/Updates
Table 124. Taimei Technology Competitive Strengths & Weaknesses
Table 125. eMedyun Basic Information, Manufacturing Base and Competitors
Table 126. eMedyun Major Business
Table 127. eMedyun Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 128. eMedyun Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. eMedyun Recent Developments/Updates
Table 130. eMedyun Competitive Strengths & Weaknesses
Table 131. Bioknow Basic Information, Manufacturing Base and Competitors
Table 132. Bioknow Major Business
Table 133. Bioknow Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 134. Bioknow Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Bioknow Recent Developments/Updates
Table 136. Bioknow Competitive Strengths & Weaknesses
Table 137. Singedi Health Basic Information, Manufacturing Base and Competitors
Table 138. Singedi Health Major Business
Table 139. Singedi Health Drug Safety and Pharmacovigilance (PV) Software Product and Services
Table 140. Singedi Health Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Singedi Health Recent Developments/Updates
Table 142. Singedi Health Competitive Strengths & Weaknesses
Table 143. Global Key Players of Drug Safety and Pharmacovigilance (PV) Software Upstream (Raw Materials)
Table 144. Global Drug Safety and Pharmacovigilance (PV) Software Typical Customers
LIST OF FIGURES
Figure 1. Drug Safety and Pharmacovigilance (PV) Software Picture
Figure 2. World Drug Safety and Pharmacovigilance (PV) Software Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Drug Safety and Pharmacovigilance (PV) Software Total Revenue (2021-2032) & (USD Million)
Figure 4. World Drug Safety and Pharmacovigilance (PV) Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032) & (USD Million)
Figure 13. Drug Safety and Pharmacovigilance (PV) Software Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 16. World Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 18. China Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 23. India Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Drug Safety and Pharmacovigilance (PV) Software by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Drug Safety and Pharmacovigilance (PV) Software Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Drug Safety and Pharmacovigilance (PV) Software Markets in 2025
Figure 27. United States VS China: Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type in 2025
Figure 31. On-Premises
Figure 32. Cloud-Based
Figure 33. World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2021-2032)
Figure 34. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Data Range, (USD Million), 2021 & 2025 & 2032
Figure 35. World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Data Range in 2025
Figure 36. Pre-market
Figure 37. Post-market
Figure 38. World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Data Range (2021-2032)
Figure 39. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Functional Modules, (USD Million), 2021 & 2025 & 2032
Figure 40. World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Functional Modules in 2025
Figure 41. Security Database
Figure 42. Signal Detection
Figure 43. Compliance Report
Figure 44. Other
Figure 45. World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Functional Modules (2021-2032)
Figure 46. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application in 2025
Figure 48. Pharma and Biotech Companies
Figure 49. Contract Research Organizations (CROs)
Figure 50. Business Process Outsourcing (BPO) Firms
Figure 51. Other
Figure 52. World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2021-2032)
Figure 53. Drug Safety and Pharmacovigilance (PV) Software Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Drug Safety and Pharmacovigilance (PV) Software Picture
Figure 2. World Drug Safety and Pharmacovigilance (PV) Software Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Drug Safety and Pharmacovigilance (PV) Software Total Revenue (2021-2032) & (USD Million)
Figure 4. World Drug Safety and Pharmacovigilance (PV) Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2032) & (USD Million)
Figure 13. Drug Safety and Pharmacovigilance (PV) Software Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 16. World Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 18. China Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 23. India Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Drug Safety and Pharmacovigilance (PV) Software by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Drug Safety and Pharmacovigilance (PV) Software Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Drug Safety and Pharmacovigilance (PV) Software Markets in 2025
Figure 27. United States VS China: Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type in 2025
Figure 31. On-Premises
Figure 32. Cloud-Based
Figure 33. World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2021-2032)
Figure 34. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Data Range, (USD Million), 2021 & 2025 & 2032
Figure 35. World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Data Range in 2025
Figure 36. Pre-market
Figure 37. Post-market
Figure 38. World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Data Range (2021-2032)
Figure 39. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Functional Modules, (USD Million), 2021 & 2025 & 2032
Figure 40. World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Functional Modules in 2025
Figure 41. Security Database
Figure 42. Signal Detection
Figure 43. Compliance Report
Figure 44. Other
Figure 45. World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Functional Modules (2021-2032)
Figure 46. World Drug Safety and Pharmacovigilance (PV) Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application in 2025
Figure 48. Pharma and Biotech Companies
Figure 49. Contract Research Organizations (CROs)
Figure 50. Business Process Outsourcing (BPO) Firms
Figure 51. Other
Figure 52. World Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2021-2032)
Figure 53. Drug Safety and Pharmacovigilance (PV) Software Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
